CAC (gated) Algorithm vs Tempus ECG-Low EF

Tool A, BunkerHill Health's CAC (gated) Algorithm, offers a clear advantage in usability by integrating directly into physicians' standard workflows and pre-populating structured reports for radiologist review and approval, significantly streamlining reporting tasks. While Tool B provides a straightforward binary output, it requires additional clinical interpretation, and its broader platform features are not specific to the ECG-Low EF product's direct output.

Tool B, Tempus ECG-Low EF, offers substantial clinical value by enabling early detection of low Left Ventricular Ejection Fraction (LVEF) from widely available and inexpensive 12-lead ECGs, with validated high sensitivity and specificity. This provides a broad screening potential for heart failure, a critical condition. While Tool A offers detailed quantification of coronary artery calcium from CT scans, Tool B's ability to identify at-risk patients earlier through a more accessible modality presents a greater population-level impact.

Both Tool A and Tool B require direct contact with the vendor for pricing information, making a direct comparison of their cost-effectiveness impossible. However, BunkerHill Health (Tool A) has secured CMS reimbursement pathways for its AI cardiovascular analysis, which could enhance its value proposition for healthcare systems by providing a clearer path to financial viability.

Tool A, through BunkerHill Health's Carebricks platform, demonstrates superior enterprise readiness by offering a 'system of action' that empowers health systems to rapidly design, deploy, and scale custom AI agents across diverse clinical and operational workflows. This platform approach, evidenced by system-wide deployment at UTMB Health, provides greater flexibility and comprehensive integration for large organizations. Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, establishing foundational readiness.

Tool A, BunkerHill Health, showcases a higher degree of innovation with its 'Generative AI for clinical reasoning and action' and 'agentic AI workflows' within the Carebricks platform, allowing health systems to build and deploy AI agents that reason and take action. This approach moves beyond traditional detection to a more flexible and adaptive AI paradigm. Additionally, BunkerHill Health has secured the first FDA clearances for AI algorithms to evaluate coronary artery calcium on contrast-enhanced chest CTs, demonstrating continuous product innovation.

Tool B, Tempus AI, provides clearly articulated support channels, including local representatives and a dedicated email address for assistance, along with a comprehensive online resource center featuring webinars, case studies, and articles. While BunkerHill Health's partnership model suggests direct implementation support, explicit general support and documentation resources are not as readily available or detailed in the provided information.